VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children
CLINICAL EXPERIENCE SINCE APPROVAL
VYNDAMAX® (tafamidis) is
ONE pill, taken once a day
for transthyretin cardiac
amyloidosis (ATTR-CM).
And, it’s delivered right to your door.
Create a discussion guide to help you log your symptoms and talk to your doctor about ATTR-CM
Find out how VYNDAMAX may help treat ATTR-CM
Looking for information on VYNDAQEL® (tafamidis meglumine)?
Watch to learn how VYNDAMAX can impact ATTR-CM
Watch to learn how VYNDAMAX can impact ATTR-CM
A Pfizer Patient Access Coordinator (PAC) is here for you
If you’ve been prescribed VYNDAMAX or VYNDAQEL, a PAC will be your go-to support person for help filling your prescription.
Receive educational materials throughout your journey
Get to the heart of what to know about ATTR-CM and VYNDAMAX
“Learn as much as you can about ATTR-CM. Be very proactive about researching it, and get a doctor who communicates well.”